Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1958820Generated: November 4, 2026

3-Formyl-5-isopropyl-benzoic acid → N-((S)-3-{2-ethyl-4-[5-(3-formyl-5-isopropyl-phenyl)-[1,2,4]oxadiazol-3-yl]-6-methyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamide

https://huagongshe.com/reaction/1958820

Reaction equation

Participants

RoleNameHCIDCharge
Reactant3-Formyl-5-isopropyl-benzoic acidHCID 86650519—
ReactantHCID 87208794HCID 87208794—
ReactantHCID 178436630HCID 178436630—
ProductN-((S)-3-{2-ethyl-4-[5-(3-formyl-5-isopropyl-phenyl)-[1,2,4]oxadiazol-3-yl]-6-methyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamideHCID 866505187.8%

Reaction Steps

The title compound (49 mg) was prepared in analogy to rac-N-(3-{4-[5-(3-formyl-phenyl)-[1,2,4]oxadiazol-3-yl]-2,6-dimethyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamide, starting from 3-formyl-5-isopropyl-benzoic acid (250 mg, 1.30 mmol) and N—((S)-3-[2-ethyl-4-(N-hydroxycarbamimidoyl)-6-methyl-phenoxy]-2-hydroxy-propyl)-2-hydroxy-acetamide (423 mg, 1.30 mmol); LC-MS**: tR=0.90 min; [M+1]+=481.85.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08410151B2
Source datasetuspto-grants-2013_04
ORD IDord-c8bea71ecc86447f927821c3006fdb95
Source noteuspto-grants-2013_04